778 related articles for article (PubMed ID: 33177086)
1. Determinants of seeding and spreading of α-synuclein pathology in the brain.
Henrich MT; Geibl FF; Lakshminarasimhan H; Stegmann A; Giasson BI; Mao X; Dawson VL; Dawson TM; Oertel WH; Surmeier DJ
Sci Adv; 2020 Nov; 6(46):. PubMed ID: 33177086
[TBL] [Abstract][Full Text] [Related]
2. Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation.
Mezias C; Rey N; Brundin P; Raj A
Neurobiol Dis; 2020 Feb; 134():104623. PubMed ID: 31628991
[TBL] [Abstract][Full Text] [Related]
3. Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson's disease.
Fares MB; Maco B; Oueslati A; Rockenstein E; Ninkina N; Buchman VL; Masliah E; Lashuel HA
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E912-21. PubMed ID: 26839406
[TBL] [Abstract][Full Text] [Related]
4. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
5. Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patterns.
Rahayel S; Mišić B; Zheng YQ; Liu ZQ; Abdelgawad A; Abbasi N; Caputo A; Zhang B; Lo A; Kehm V; Kozak M; Yoo HS; Dagher A; Luk KC
Brain; 2022 Jun; 145(5):1743-1756. PubMed ID: 34910119
[TBL] [Abstract][Full Text] [Related]
6. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.
Recasens A; Dehay B; Bové J; Carballo-Carbajal I; Dovero S; Pérez-Villalba A; Fernagut PO; Blesa J; Parent A; Perier C; Fariñas I; Obeso JA; Bezard E; Vila M
Ann Neurol; 2014 Mar; 75(3):351-62. PubMed ID: 24243558
[TBL] [Abstract][Full Text] [Related]
7. Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term.
Rey NL; George S; Steiner JA; Madaj Z; Luk KC; Trojanowski JQ; Lee VM; Brundin P
Acta Neuropathol; 2018 Jan; 135(1):65-83. PubMed ID: 29209768
[TBL] [Abstract][Full Text] [Related]
8. Selective neuronal vulnerability in Parkinson disease.
Surmeier DJ; Obeso JA; Halliday GM
Nat Rev Neurosci; 2017 Jan; 18(2):101-113. PubMed ID: 28104909
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer.
Musgrove RE; Helwig M; Bae EJ; Aboutalebi H; Lee SJ; Ulusoy A; Di Monte DA
J Clin Invest; 2019 Jun; 129(9):3738-3753. PubMed ID: 31194700
[TBL] [Abstract][Full Text] [Related]
10. The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson's Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline.
Borghammer P
J Parkinsons Dis; 2021; 11(2):455-474. PubMed ID: 33682732
[TBL] [Abstract][Full Text] [Related]
11. α-Synuclein and Lewy pathology in Parkinson's disease.
Kalia LV; Kalia SK
Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
[TBL] [Abstract][Full Text] [Related]
12. Propagation of pathological α-synuclein in marmoset brain.
Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M
Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299
[TBL] [Abstract][Full Text] [Related]
13. Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes.
Chu Y; Muller S; Tavares A; Barret O; Alagille D; Seibyl J; Tamagnan G; Marek K; Luk KC; Trojanowski JQ; Lee VMY; Kordower JH
Brain; 2019 Nov; 142(11):3565-3579. PubMed ID: 31580415
[TBL] [Abstract][Full Text] [Related]
14. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.
Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073
[TBL] [Abstract][Full Text] [Related]
15. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
Henderson MX; Trojanowski JQ; Lee VM
Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
[TBL] [Abstract][Full Text] [Related]
16. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease.
Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K
Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963
[TBL] [Abstract][Full Text] [Related]
17. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
[TBL] [Abstract][Full Text] [Related]
18. Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients.
Recasens A; Carballo-Carbajal I; Parent A; Bové J; Gelpi E; Tolosa E; Vila M
Acta Neuropathol Commun; 2018 Feb; 6(1):8. PubMed ID: 29422109
[TBL] [Abstract][Full Text] [Related]
19. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition and knockdown of O-GlcNAcase reduces cellular internalization of α-synuclein preformed fibrils.
Tavassoly O; Yue J; Vocadlo DJ
FEBS J; 2021 Jan; 288(2):452-470. PubMed ID: 32365408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
